《港樓》黃竹坑滶晨II再沽5伙 套現7,665萬
新世界發展(00017.HK)夥拍帝國集團、資本策略地產(00497.HK)、麗新發展(00488.HK)及港鐵(00066.HK)合作發展,黃竹坑站滶晨II單日再沽5伙,套現7,665萬,其中滶晨II第2座23樓P1單位,透過招標形式售出,實用面積778平方呎,屬三房套及工作間連洗手間設計,呎價29,100元,售價2,264萬元。
滶晨II亦以價單形式售出4伙,套現5,401萬,成交價介乎944.6萬至2,095.1萬,成交呎價20,852至26,929元。
滶晨及滶晨II合共售出514伙,約70%選用即供付款方法,平均成交呎價近2.7萬元,共套現逾90億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.